Intrepida Bio
San Diego
About Intrepida Bio
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $9.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2019)
- Website: intrepidabio.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/intrepida-bio-157662 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.